Skip to content

Journal · Aging research · Updated 22 November 2026

Biogerontology

Read Biogerontology articles on DeepDyve. No university library needed.

Biogerontology publishes research on the biology of aging, from cellular senescence and the senescence-associated secretory phenotype to FOXO signaling, epigenetics and how to define healthspan. Springer Nature publishes it, and it has published since 2000. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.

Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.

Personal plans aren’t for business use. Reading for work? See Enterprise.

Cover of Biogerontology
Journal cover

Biogerontology at a glance

Full title
Biogerontology
Abbreviation (NLM)
Biogerontology
Publisher
Springer Nature
Print ISSN
1389-5729
Online ISSN (eISSN)
1573-6768
First published
2000
Subjects
Geriatrics
Access model
Hybrid (21% free to read in 2026)

Ways to access Biogerontology

21% of the articles Biogerontology published from January 1 to November 20, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.

  1. Open access articles. 21% of Biogerontology articles published from January 1 to November 20, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
  2. The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
  3. Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
  4. NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
  5. A library. Your university, hospital or public library may subscribe to Biogerontology. Check its journal list and whether it offers remote access.
  6. DeepDyve. Read Biogerontology articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.

Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.

Impact factor and metrics

Biogerontology’s 2025 Journal Impact Factor is 5.3, and its 5-year Impact Factor is 5.2.

5.3

Journal Impact Factor (2025)

5.2

5-year Impact Factor (2025)

4 days

Median time to first decision

Source: journal metrics on the Biogerontology homepage (Springer Nature), checked November 22, 2026. Impact Factor from Clarivate Journal Citation Reports.

Recent Biogerontology research worth reading

Published January to May 2026. Summaries describe what the authors report.

  1. Open accessCellular senescence · Epigenetics

    Neuroendocrine-associated epigenetic factors in cellular senescence: mechanisms and therapeutic implications

    The authors review how neuroendocrine signals such as the HPA axis and IGF-1 drive cellular senescence through chromatin remodelling, histone modifications and DNA methylation, and discuss hormonal regulation combined with epigenetic drugs as ways to postpone senescence.

    Jayaraman et al. · Biogerontology, published online February 26, 2026 · DOI 10.1007/s10522-026-10402-7

  2. LitStreamFOXO · Longevity

    FOXO: a key target in regulating aging and age-related diseases

    The authors review how FOXO transcription factors link insulin/IGF signaling, autophagy and oxidative stress responses to aging, their dual roles in neurodegenerative, metabolic and cancer diseases, and drugs targeting the pathway such as metformin, resveratrol and berberine.

    Wang et al. · Biogerontology, published online January 12, 2026 · DOI 10.1007/s10522-025-10380-2

  3. LitStreamReplicative senescence · Cell cycle

    G1/S arrest: a key mechanism of cellular aging and replicative senescence

    Drawing on newer single-cell models, the authors review how DNA damage from continuous passaging activates the p53-p21 pathway in mother G2 and daughter G1, with the p16-Rb pathway later enforcing the irreversible cell cycle arrest of replicative senescence.

    Li et al. · Biogerontology, published online January 16, 2026 · DOI 10.1007/s10522-025-10378-w

  4. LitStreamSenescence · Inflammaging

    Senescent cells in systemic aging: SASP heterogeneity, immune escape, and endocrine modulation

    The authors review tissue-specific secretory programs of senescent cells, how they evade immune clearance, and how endocrine signaling, extracellular vesicles and sex-dependent factors amplify local senescence into the organism-wide inflammation known as inflammaging.

    Abo Qoura et al. · Biogerontology, published online May 11, 2026 · DOI 10.1007/s10522-026-10449-6

See every Biogerontology article on DeepDyve

Questions about Biogerontology

How can I read Biogerontology articles without a subscription?

21% of Biogerontology articles published from January 1 to November 20, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Biogerontology articles online for $59 a month or $499 a year after a free first month.

What is the abbreviation for Biogerontology?

Biogerontology isn’t abbreviated: its NLM (PubMed) abbreviation is simply Biogerontology.

What is the ISSN of Biogerontology?

The print ISSN is 1389-5729 and the online ISSN is 1573-6768.

What is the impact factor of Biogerontology?

Biogerontology’s Journal Impact Factor is 5.3 (2025), and its 5-year Impact Factor is 5.2, according to Springer Nature’s published metrics.

Is Biogerontology open access?

Biogerontology is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 20, 2026, 34 of 161 Biogerontology articles (21%) carry a Creative Commons license, per Crossref.

Biogerontology articles on DeepDyve are licensed from Springer Nature. Journal facts as of 22 November 2026.

Start reading Biogerontology today

One month free, then less than $2 a day. Biogerontology, plus millions of articles from thousands of journals.

Start free month

Like this: